BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27743701)

  • 1. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.
    Wills AA; Elm JJ; Ye R; Chou KL; Parashos SA; Hauser RA; Bodis-Wollner I; Hinson VK; Christine CW; Schneider JS;
    Parkinsonism Relat Disord; 2016 Dec; 33():127-133. PubMed ID: 27743701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of cognitive impairment and psychiatric complications in Parkinson's disease.
    Campos LS; Guimarães RP; Piovesana LG; Azevedo PC; Santos LM; D'Abreu A
    Arq Neuropsiquiatr; 2015 May; 73(5):390-5. PubMed ID: 26017203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended "Timed Up and Go" assessment as a clinical indicator of cognitive state in Parkinson's disease.
    Evans T; Jefferson A; Byrnes M; Walters S; Ghosh S; Mastaglia FL; Power B; Anderton RS
    J Neurol Sci; 2017 Apr; 375():86-91. PubMed ID: 28320196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.
    Wills AM; Li R; Pérez A; Ren X; Boyd J;
    J Neurol; 2017 Aug; 264(8):1746-1753. PubMed ID: 28712000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.
    Bega D; Kim S; Zhang Y; Elm J; Schneider J; Hauser R; Fraser A; Simuni T
    J Parkinsons Dis; 2015; 5(4):773-82. PubMed ID: 26639661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].
    Martínez-Martín P; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2008 Oct 1-15; 47(7):337-43. PubMed ID: 18841543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.
    Ng A; Chander RJ; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric attributes of the SCOPA-COG Brazilian version.
    Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
    Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.
    Minett T; Su L; Mak E; Williams G; Firbank M; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn D; O'Brien JT
    J Neurol; 2018 Jul; 265(7):1528-1539. PubMed ID: 29696499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
    Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
    Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Lundin KF; Edström M; Forsgren L
    Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.